iX Biopharma Ltd. | Income Statement
Fiscal year is July-June. All values SGD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
6,487.00
7,445.00
5,797.00
6,381.00
6,533.00
Cost of Goods Sold (COGS) incl. D&A
8,468.60
4,166.00
4,090.00
4,448.00
5,156.00
Gross Income
1,981.60
3,279.00
1,707.00
1,933.00
1,377.00
SG&A Expense
3,434.10
11,912.00
12,375.00
12,404.00
17,911.00
EBIT
5,415.70
-
10,668.00
10,436.00
16,534.00
Unusual Expense
117.40
1,250.00
157.00
-
-
Non Operating Income/Expense
205.10
980.00
817.00
1,093.00
216.00
Interest Expense
31.00
47.00
47.00
242.00
267.00
Pretax Income
5,689.20
10,853.00
11,655.00
9,449.00
16,362.00
Income Tax
606.40
292.00
3,952.00
2,059.00
1,268.00
Consolidated Net Income
5,082.80
10,561.00
7,703.00
7,390.00
15,094.00
Net Income
5,082.80
10,561.00
7,703.00
7,390.00
15,094.00
Net Income After Extraordinaries
5,082.80
10,561.00
7,703.00
7,390.00
15,094.00
Net Income Available to Common
5,082.80
10,561.00
7,703.00
7,390.00
15,094.00
EPS (Basic)
0.01
0.02
0.01
0.01
0.02
Basic Shares Outstanding
598,337.30
509,373.90
595,408.00
638,406.40
641,549.00
EPS (Diluted)
0.01
0.02
0.01
0.01
0.02
Diluted Shares Outstanding
598,337.30
509,373.90
595,408.00
638,406.40
641,549.00
EBITDA
4,353.20
7,741.00
9,736.00
9,155.00
15,127.00
Other Operating Expense
-
-
-
35.00
-
Non-Operating Interest Income
80.00
57.00
34.00
136.00
223.00
About iX Biopharma
View Profile
